Polyunsaturated fatty acid supplements modulate mast cell membrane microdomain composition

Cellular Immunology

Volumn 275, Issue 1-2, 2012, Pages 42-46

  Basiouni, Shereen ^a,b   Stöckel, Katja ^a   Fuhrmann, Herbert ^a   Schumann, Julia ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Benha University   (Egypt)

Author keywords

Lipid rafts; Mast cells; Membrane fatty acid profiles; PUFA

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; LIPID ANALYSIS; LIPID COMPOSITION; LIPID RAFT; MAST CELL; MASTOCYTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; CELL LINE; DOGS; FATTY ACIDS, UNSATURATED; MAST CELLS; MEMBRANE MICRODOMAINS;

EID: 84860547480     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.03.004     Document Type: Article

References (37)

1. Das U.N. Beneficial effects of eicosapentaenoic acid in coronary heart disease with peripheral vascular diseases: but how and why?. Circ. J. 2010, 74:1451-1457.
2. Ogilvie G.K., Fettman M.J., Mallinckrodt C.H., Walton J.A., Hansen R.A., Davenport D.J., Gross K.L., Richardson K.L., Rogers Q., Hand M.S. Effect of fish oil, arginine and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma-a double-blind, randomized placebo-controlled study. Cancer 2000, 88:1916-1928.
3. Laurent G., Moe G., Hu X., Holub B., Leong-Poi H., Trogadis J., Connelly K., Courtman D., Strauss B.H., Dorian P. Long chain n-3 polyunsaturated fatty acids reduce a trial vulnerability in a novel canine pacing model. Cardiovasc. Res. 2008, 77:89-97.
4. Smith C.E., Freeman L.M., Rush J.E., Cunningham S.M., Biourge V. Omega-3 fatty acids in boxer dogs with arrhythmogenic right ventricular cardiomyopathy. J. Vet. Intern. Med. 2007, 21:265-273.
5. Brown S.A., Brown C.A., Crowell W.A., Barsanti J.A., Kang C.W., Allen T., Cowell C., Finco D.R. Effects of dietary polyunsaturated fatty acid supplementation in early renal insufficiency in dogs. J. Lab. Clin. Med. 2000, 35:275-286.
6. Neumayer H.H., Heinrich M., Schmissas M., Haller H., Wagner K., Luft F.C. Amelioration of ischemic acute-renal-failure by dietary fish oil administration in conscious dogs. J. Am. Soc. Nephrol. 1992, 3:1312-1320.
7. Gueck T., Seidel A., Fuhrmann H. Effects of essential fatty acids on mediators of mast cells in culture. Prostaglandins Leukot. Essent. Fatty Acids 2003, 68:317-322.
8. Gueck T., Seidel A., Baumann D., Meister A., Fuhrmann H. Alterations of mast cell mediator production and release by gamma-linolenic and docosahexaenoic acid. Vet. Dermatol. 2004, 15:309-314.
9. Gueck T., Seidel A., Fuhrmann H. Consequences of eicosapentaenoic acid (n-3) and arachidonic acid (n-6) supplementation on mast cell mediators. J. Anim. Physiol. Anim. Nutr. 2004, 88:259-265.
10. Stillwell W., Wassall S.R. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem. Phys. Lipids 2003, 126:1-27.
11. Wassall S.R., Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem. Phys. Lipids 2008, 153:57-63.
12. Pike L.J. Lipid rafts: bringing order to chaos. J. Lipid Res. 2003, 44:655-667.
13. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
14. DeVinney R., Gold W.M. Establishment of 2 dog mastocytoma cell-lines in continuous culture. Am. J. Respir. Cell Mol. Biol. 1990, 3:413-420.
15. Lazarus S.C., Mccabe L.J., Nadel J.A., Gold W.M., Leikauf G.D. Effects of mast cell derived mediators on epithelial cells in canine trachea. Am. J. Physiol. 1986, 251:387-394.
16. MacDonald J.L., Pike L.J. A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 2005, 46:1061-1067.
17. Schumann J., Leichtle A., Thiery J., Fuhrmann H. Fatty acid and peptide profiles in plasma membrane and membrane rafts of PUFA supplemented RAW264.7 macrophages. PLoS One 2011, 6:e24066.
18. Surviladze Z., Harrison K.A., Murphy R.C., Wilson B.S. Fc epsilon RI and Thy-1 domains have unique protein and lipid compositions. J. Lipid Res. 2007, 48:1325-1335.
19. Dhungana S., Merrick B.A., Tomer K.B., Fessler M.B. Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide. Mol. Cell. Proteomics 2009, 8:201-213.
20. Gaus K., Rodriguez M., Ruberu K.R., Gelissen I., Sloane T.M., Kritharides L., Jessup W. Domain-specific lipid distribution in macrophage plasma membranes. J. Lipid Res. 2005, 46:1526-1538.
21. Iwami D., Nonomura K., Shirasugi N., Niimi M. Immunomodulatory effects of eicosapentaenoic acid through induction of regulatory T cells. Int. Immunopharmacol. 2011, 11:384-389.
22. Kelley E.E., Buettner G.R., Burns C.P. Relative alpha tocopherol deficiency in cultured cells-free radical-mediated lipid-peroxidation, lipid oxidizability and cellular polyunsaturated fatty acid content. Arch. Biochem. Biophys. 1995, 319:102-109.
23. Drevot P., Langlet C., Guo X.J., Bernard A.M., Colard O., Chauvin J.P., Lasserre R., He H.T. TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. Embo J. 2002, 21:1899-1908.
24. Lingwood D., Simons K. Detergent resistance as a tool in membrane research. Nat. Protoc. 2007, 2:2159-2165.
25. London E., Brown D.A. Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (Rafts). BBA-Biomembranes 2000, 1508:182-195.
26. Heerklotz H. Triton promotes domain formation in lipid raft mixtures. Biophys. J. 2002, 83:2693-2701.
27. Heerklotz H., Seelig J. Sphingomyelin hates triton. Biophys. J. 2003, 84:326A.
28. Anderson R.G.W., Jacobson K. Cell biology-a role for lipid shells in targeting proteins to caveolae, rafts and other lipid domains. Science 2002, 296:1821-1825.
29. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 2003, 32:257-283.
30. Leaf D.A., Connor W.E., Barstad L., Sexton G. Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes. Am. J. Clin. Nutr. 1995, 62:68-73.
31. Xavier R., Brennan T., Li Q., McCormack C., Seed B. Membrane compartmentation is required for efficient T cell activation. Immun. 1998, 8:723-732.
32. Viola A., Schroeder S., Sakakibara Y., Lanzavecchia A. T lymphocyte co stimulation mediated by reorganization of membrane microdomains. Science 1999, 283:680-682.
33. Yaqoob P. Mechanisms underlying the immunomodulatory effects of n-3 PUFA. Proc. Nutr. Soc. 2010, 3:311-315.
34. Siddiqui R.A., Harvey K.A., Zaloga G.P., Stillwell W. Modulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support. Nutr. Clin. Pract. 2007, 1:74-88.
35. Chapkin R.S., Seo J., McMurray D.N. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem. Phys. Lipids 2008, 153:14-23.
36. Davey A.M., Walvick R.P., Liu Y., Heikal A.A., Sheets E.D. Membrane order and molecular dynamics associated with IgE receptor cross-linking in mast cells. Biophys. J. 2007, 92:343-355.
37. Davey A.M., Krise K.M., Sheets E.D., Heikal A.A. Molecular perspective of antigen-mediated mast cell signalling. J. Biol. Chem. 2008, 283:7117-7127.